Nine Masts Capital LTD Legend Biotech Corp Transaction History
Nine Masts Capital LTD
- $906 Million
- Q4 2024
A detailed history of Nine Masts Capital LTD transactions in Legend Biotech Corp stock. As of the latest transaction made, Nine Masts Capital LTD holds 38,466 shares of LEGN stock, worth $1.36 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
38,466
Previous 13,609
182.65%
Holding current value
$1.36 Million
Previous $663,000
88.69%
% of portfolio
0.14%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
227Shares Held
73.7MCall Options Held
238KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$395 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$266 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$235 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$202 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$178 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.92B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...